In this study, we utilized a cell‐permeable JNK‐inhibitory peptide (CPJIP) known for its ability to regulate glucose metabolism and improve diabetes, to investigate its effectiveness in regulating experimental NEC both in vitro and in vivo. This evidence concerns the gene MAPK8 and necrotizing enterocolitis.